Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 227-231

  Pigny, Pascal ^a   Cardot Bauters, Catherine ^a   Do Cao, Christine ^a   Vantyghem, Marie Christine ^a   Carnaille, Bruno ^a   Pattou, François ^a   Caron, Philippe ^b   Wemeau, Jean Louis ^a   Porchet, Nicole ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b SERVICE DE PNEUMOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE; NEUROFIBROMIN; PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; THYMIDINE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ACCURACY; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PHENOTYPE; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY ANALYSIS; ADRENAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGE OF ONSET; COST-BENEFIT ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PHEOCHROMOCYTOMA; PREVALENCE; YOUNG ADULT;

EID: 61449266628     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0574     Document Type: Article

References (12)

1. Lewis CE & Yeh MW. Molecular Genetics and Metabolism 2008 94 271-282.
2. Dahia PL. Evolving concepts in pheochromocytoma and paraganglioma. Current Opinion in Oncology 2006 18 1-8.
3. Schlisio S, Kenchappa RS, Vredeveld LCW, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look T, Meyerson M, Peeper DS, Carter BD & Kaelin WG. The kinesin KIFB acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes and Development 2008 22 884-893.
4. Neumann HP, Bausch B, McWhinney SR, Bender B, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Erres K, Januszewic A & Eng C. Germline mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 2002 346 1459-1466.
5. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, Wemeau JL, Proye C & Pigny P. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. Journal of Medical Genetics 2003 40 e75.
6. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, Neumann H, Opocher G, Maher ER & Plouin PF. Phaeochromocytoma, new genes and screening strategies. Clinical Endocrinology 2006 65 699-705.
7. Bayley JP, Deville P & Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Medical Genetics 2005 6 39.
8. Patocs A, Gergics P, Balogh K, Toth M, Fazakas F, Liko O & Racz K. Ser80Ile mutation and a concurrent Pro25Leu variant of the VHL gene in an extented Hungarian von Hippel-Lindau family. BMC Medical Genetics 2008 9 29.
9. Synthèse Nationale de L'évolution de L'activité D'oncogénétique 2003-2006. Institut National du Cancer, Mars 2008.
10. Jimenez C, Cote G, Arnold A & Gagel RF. Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? Journal of Clinical Endocrinology and Metabolism 2006 91 2851-2858.
11. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM & Tischler AS. Pheochromocytoma: recommendations for clinical practice from the first International Symposium. Nature Clinical Practice. Endocrinology & Metabolism 2007 3 92-102.
12. Pawlu C, Bausch B, Reisch N & Neumann HPH. Genetic testing for pheochromocytoma-associated syndromes. Annales d'Endocrinologie 2005 66 178-185.